Your browser is no longer supported. Please, upgrade your browser.
Settings
KERX Keryx Biopharmaceuticals Inc. daily Stock Chart
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.46 Insider Own0.80% Shs Outstand107.29M Perf Week4.58%
Market Cap490.32M Forward P/E- EPS next Y-0.49 Insider Trans-2.46% Shs Float101.79M Perf Month-37.91%
Income-154.10M PEG- EPS next Q-0.21 Inst Own64.50% Short Float16.88% Perf Quarter-22.01%
Sales26.10M P/S18.79 EPS this Y3.30% Inst Trans-1.98% Short Ratio10.27 Perf Half Y13.68%
Book/sh0.57 P/B8.02 EPS next Y60.50% ROA-72.10% Target Price7.14 Perf Year-26.29%
Cash/sh- P/C- EPS next 5Y- ROE-194.30% 52W Range2.80 - 7.80 Perf YTD-9.50%
Dividend- P/FCF- EPS past 5Y-27.90% ROI-62.00% 52W High-41.41% Beta4.22
Dividend %- Quick Ratio7.00 Sales past 5Y- Gross Margin50.70% 52W Low63.21% ATR0.32
Employees184 Current Ratio8.70 Sales Q/Q272.00% Oper. Margin- RSI (14)37.64 Volatility6.68% 5.93%
OptionableYes Debt/Eq2.11 EPS Q/Q-64.10% Profit Margin- Rel Volume0.76 Prev Close4.63
ShortableYes LT Debt/Eq2.11 EarningsAug 01 BMO Payout- Avg Volume1.67M Price4.57
Recom2.80 SMA200.18% SMA50-22.74% SMA200-9.76% Volume1,263,946 Change-1.30%
Aug-02-16Downgrade Stifel Buy → Hold
Aug-02-16Downgrade FBR Capital Outperform → Mkt Perform $16 → $7
Aug-02-16Downgrade Brean Capital Buy → Hold
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-08-16Reiterated Maxim Group Buy $7 → $9
Mar-30-16Reiterated FBR Capital Outperform $10 → $13
Feb-29-16Upgrade FBR Capital Mkt Perform → Outperform $10
Feb-26-16Upgrade Raymond James Mkt Perform → Outperform
Feb-26-16Reiterated Stifel Buy $10 → $9
Feb-26-16Downgrade JP Morgan Overweight → Neutral
Feb-25-16Reiterated Maxim Group Buy $11 → $5
Oct-05-15Upgrade Morgan Stanley Underweight → Equal-Weight
Sep-09-15Initiated Raymond James Mkt Perform
Sep-03-15Initiated Citigroup Sell
Aug-13-15Initiated Morgan Stanley Underweight $3
Aug-11-15Initiated FBR Capital Mkt Perform $10
Aug-10-15Downgrade ROTH Capital Buy → Neutral $11 → $6
Aug-06-15Reiterated Maxim Group Buy $17 → $11
Jul-23-15Reiterated ROTH Capital Buy $23 → $11
May-06-15Reiterated Mizuho Buy $25 → $21
Aug-26-16 10:07PM  KERYX SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Keryx Biopharmaceuticals Inc. - KERX Business Wire
09:00PM  Keryx Biopharmaceuticals, Inc. Sued By Block & Leviton For Violations Of The Federal Securities Laws PR Newswire
08:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - KERX Accesswire
02:46PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
09:58AM  KERX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Keryx Biopharmaceuticals, Inc. and a Lead Plaintiff Deadline of October 3, 2016 GlobeNewswire
05:45AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
Aug-25-16 10:00PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Keryx Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit KERX GlobeNewswire
Aug-23-16 12:57PM  EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire +6.11%
10:06AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) & Lead Plaintiff Deadline: October 3, 2016 Accesswire
Aug-22-16 08:32PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
11:04AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Keryx Biopharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 3, 2016 KERX GlobeNewswire
Aug-19-16 07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline KERX GlobeNewswire
04:58PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
02:59PM  Robbins Arroyo LLP: Keryx Biopharmaceuticals, Inc. (KERX) Misled Shareholders According to a Recently Filed Class Action Business Wire
Aug-18-16 06:34PM  ETFs with exposure to Keryx Biopharmaceuticals, Inc. : August 18, 2016
03:15PM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
11:55AM  5 Breakout Stocks Under $10 Set to Soar
09:30AM  Hagens Berman Reminds Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) of October 3, 2016 Lead Plaintiff Deadline in Securities Class Action GlobeNewswire
Aug-17-16 05:41PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
11:00AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Keryx Biopharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 3, 2016 - KERX Accesswire
Aug-16-16 01:04PM  KERYX BIOPHARMACEUTICALS INC Financials
11:48AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
10:06AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) & Lead Plaintiff Deadline: October 3, 2016 Accesswire
Aug-15-16 03:45PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
Aug-14-16 10:40AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) and Lead Plaintiff Deadline October 3, 2016 Accesswire
Aug-12-16 11:44PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
10:07PM  KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX PR Newswire
08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - KERX PR Newswire
01:45PM  INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
12:14PM  SHAREHOLDER ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important Deadline in Class Action - KERX Business Wire
10:41AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Keryx Biopharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 3, 2016 -- KERX Marketwired
10:05AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) and Lead Plaintiff Deadline: October 3, 2016 Accesswire
Aug-11-16 05:30PM  IMPORTANT KERYX BIOPHARMACEUTICALS INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces that a Class Action Lawsuit has been Commenced on Behalf of Shareholders of Keryx Biopharmaceuticals, Inc. Accesswire
03:50PM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Keryx Biopharmaceuticals, Inc. Business Wire
02:53PM  SHAREHOLDER DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
01:40PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Keryx Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
11:43AM  DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
11:38AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) and Lead Plaintiff Deadline: October 3, 2016 PR Newswire
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Keryx Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
Aug-10-16 06:26PM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Accesswire
03:57PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed against Keryx Biopharmaceuticals, Inc. (KERX) and Encourages Investors to Contact the Firm Business Wire
01:07PM  Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-09-16 08:02PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
07:15PM  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. PR Newswire
11:52AM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
09:47AM  Block & Leviton LLP Announces The Filing Of A Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. For Violations Of The Federal Securities Laws PR Newswire
Aug-08-16 02:43PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -6.24%
01:23PM  KERX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Keryx Biopharmaceuticals, Inc. and a Lead Plaintiff Deadline of October 3, 2016 GlobeNewswire
11:33AM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm Business Wire
Aug-07-16 10:15AM  6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Aug-05-16 10:07PM  KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX Marketwired +6.65%
05:43PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Keryx Biopharmaceuticals, Inc. and Certain Officers KERX GlobeNewswire
05:33PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
12:52PM  INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm Business Wire
Aug-04-16 07:35PM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Keryx Biopharmaceuticals, Inc. PR Newswire
03:27PM  IMPORTANT NOTICE TO SHAREHOLDERS: Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Keryx Pharmaceuticals, Inc. To Contact Brower Piven Be GlobeNewswire
03:01PM  ETFs with exposure to Keryx Biopharmaceuticals, Inc. : August 4, 2016
11:11AM  IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
09:30AM  INVESTOR ALERT: Hagens Berman Alerts Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) to October 3, 2016 Lead Plaintiff Deadline in Securities Class Action GlobeNewswire
Aug-03-16 10:07PM  KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX GlobeNewswire
02:41PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Keryx Biopharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 3, 2016 KERX GlobeNewswire
12:47PM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
12:07PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. Business Wire
10:06AM  INVESTOR ALERT: Class Action Lawsuit on Behalf of Investors in Keryx Biopharmaceuticals Announced by Holzer & Holzer Business Wire
Aug-02-16 10:14PM  SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -8.90%
05:02PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Keryx Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
03:08PM  Keryx Biopharmaceuticals (KERX) Stock Continues to Fall on Disrupted Production
02:02PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keryx Biopharmaceuticals Inc. - KERX PR Newswire
02:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Keryx Biopharmaceuticals Inc. (KERX) PR Newswire
01:33PM  [$$] Keryx Tries to Work Out the Kinks at Barrons.com
01:22PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Keryx Biopharmaceuticals Inc. Business Wire
12:08PM  INVESTOR ALERT: Investigation of Keryx Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith Business Wire
11:55AM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Keryx Biopharmaceuticals Inc. and Advises Investors with Losses to Contact the Firm Business Wire
11:46AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Keryx Biopharmaceuticals, Inc. Business Wire
11:22AM  Keryx Biopharmaceuticals Inc. Investigated For Securities Fraud By Block & Leviton After Keryx Halts The Distribution Of Auryxia And Withdraws Its Full-Year Financial Forecast PR Newswire
10:50AM  Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in Keryx Biopharmaceuticals, Inc. PR Newswire
10:40AM  Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : KERX-US : August 2, 2016
10:10AM  Company News for August 02, 2016
09:45AM  INVESTOR ALERT: Investigation of Keryx Biopharmaceuticals Announced by Holzer & Holzer LLC Business Wire
09:36AM  Keryx Biopharmaceuticals (KERX) is Oversold: Can It Recover?
09:19AM  The Market In 5 Minutes: Futures Trending Lower For Seventh Session In A Row
09:17AM  Keryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues
05:46AM  Keryx Biopharma downgraded by FBR Capital and Stifel
Aug-01-16 08:53PM  INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Keryx Biopharmaceuticals Inc. and Advises Investors with Losses to Contact the Firm Business Wire -35.87%
06:41PM  Glancy Prongay & Murray Commences Investigation on Behalf of Keryx Pharmaceuticals, Inc. Investors Business Wire
01:36PM  A Closer Look at Five Stocks on the Move on Monday at Insider Monkey
12:12PM  Why Keryx Biopharmaceuticals (KERX) Stock Is Plummeting Today
11:45AM  Edited Transcript of KERX earnings conference call or presentation 1-Aug-16 12:30pm GMT
10:45AM  Can Keryx Biopharma Bounce Back From This Supply Interruption? at 24/7 Wall St.
10:19AM  [$$] Keryx Halts Supply of Its Only Drug After Manufacturing Issue at The Wall Street Journal
09:22AM  Keryx (KERX) Q2 Loss Wider than Expected, Withdraws View
09:13AM  Keryx Biopharmaceuticals Investors Worried Over Supply Interruption Of Auryxia, Guidance Withdrawal
08:30AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today
07:51AM  Keryx withdraws 2016 forecast on renal drug supply interruption
07:47AM  Keryx Biopharmaceuticals says kidney disease drug won't be available until the fourth quarter; stock halted at MarketWatch
07:37AM  Keryx Biopharma reports 2Q loss
07:36AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financi
07:30AM  Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q2 2016 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open
Jul-29-16 05:13PM  Keryx (KERX) Q2 Earnings Preview: Will the Stock Gain?
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, as well as treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. The company has licensing and collaboration agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Auryxia in Japan. It also has strategic alliance with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Madison GregPresident and CEOAug 09Sale4.221,6226,845257,123Aug 11 05:44 PM
Madison GregPresident and CEOAug 09Sale4.221,6226,845257,123Aug 11 05:45 PM
Holmes Scott AChief Financial OfficerJul 29Sale7.364,93536,322108,557Aug 02 05:00 PM
Neylan John F.Chief Medical OfficerJul 25Sale7.431,2179,04292,767Jul 27 05:00 PM
Adams BrianVP and General CounselJul 15Sale7.011,0837,592103,320Jul 18 07:10 PM
Madison GregPresident and CEOJul 05Sale6.669366,234258,745Jul 06 04:17 PM
Adams BrianVP and General CounselJul 05Sale6.666604,396104,403Jul 06 04:18 PM
Madison GregPresident and CEOMay 09Sale5.421,87310,152259,681May 10 04:35 PM
Neylan John F.Chief Medical OfficerApr 25Sale5.214,76624,83193,984Apr 27 04:16 PM
Adams BrianVP and General CounselApr 15Sale5.051,0605,353105,063Apr 18 08:25 PM
Madison GregPresident and CEOApr 05Sale4.501,0784,851261,554Apr 07 05:01 PM
Adams BrianVP and General CounselApr 05Sale4.507593,416106,123Apr 07 05:00 PM
Madison GregPresident and CEOFeb 09Sale3.231,9386,260262,632Feb 10 05:23 PM
Adams BrianVP and General CounselJan 15Sale3.301,3224,36353,132Jan 20 05:05 PM
Adams BrianVP and General CounselJan 06Sale5.163,00415,50154,454Jan 06 09:44 PM
Madison GregPresident and CEOJan 06Sale4.834,26120,581110,820Jan 06 09:43 PM
Madison GregPresident and CEONov 09Sale5.181,6388,485115,081Nov 12 05:00 PM
Holmes Scott AChief Financial OfficerNov 04Buy5.401,3287,17159,742Nov 05 05:01 PM
Holmes Scott AChief Financial OfficerNov 03Buy5.303,67219,45858,414Nov 05 05:01 PM
Adams BrianVP and General CounselOct 15Sale4.011,0114,05457,458Oct 19 05:33 PM